The past year has proven that the medical world is at the forefront of human innovation. The pharmaceutical industry is our weapon of choice against the COVID-19 pandemic, whilst simultaneously tackling other diseases, treatments and cures, thus extending our life expectancy age. Samuel Speltdoorn at Brussels Airport discusses how the developments and manufacturing of recent biopharmaceuticals are groundbreaking, although the logistics behind them are often overlooked and ignored at the board level, resulting in an undervaluation of a well-organised supply chain.